SOADOR
ALXN

State of Alaska Department of Revenue’s Alexion Pharmaceuticals ALXN Stock Holding History

State of Alaska Department of Revenue’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-115,895
Closed -$21.3M – 1665
2021
Q2 		$21.3M Buy
115,895
+79,407
+218% +$13.6M 0.22% 87
2021
Q1 		$5.58M Sell
36,488
-537
-1% -$83.1K 0.06% 354
2020
Q4 		$5.78M Sell
37,025
-1,863
-5% -$239K 0.07% 325
2020
Q3 		$4.45M Sell
38,888
-33,398
-46% -$3.6M 0.05% 362
2020
Q2 		$8.11M Buy
72,286
+20,699
+40% +$2.2M 0.1% 255
2020
Q1 		$4.63M Buy
51,587
+2,796
+6% +$274K 0.07% 325
2019
Q4 		$5.28M Sell
48,791
-15,875
-25% -$1.7M 0.07% 374
2019
Q3 		$6.33M Buy
64,666
+25,832
+67% +$2.91M 0.09% 325
2019
Q2 		$5.08M Sell
38,834
-1,186
-3% -$153K 0.09% 268
2019
Q1 		$5.41M Sell
40,020
-3,240
-7% -$403K 0.1% 241
2018
Q4 		$4.21M Buy
43,260
+3,157
+8% +$373K 0.08% 269
2018
Q3 		$5.57M Buy
40,103
+863
+2% +$108K 0.09% 235
2018
Q2 		$4.87M Buy
39,240
+9,540
+32% +$1.11M 0.09% 258
2018
Q1 		$3.31M Buy
29,700
+3,710
+14% +$443K 0.07% 334
2017
Q4 		$3.11M Buy
25,990
+21,730
+510% +$2.65M 0.07% 305
2017
Q3 		$597K Buy
+4,260
New +$579K 0.03% 644

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

State of Alaska Department of Revenue's ALXN Position: Q3 2021 in Review

State of Alaska Department of Revenue sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 115,895 shares — an estimated $21.3M sold.

State of Alaska Department of Revenue first reported a position in ALXN in Q3 2017 and held it in 16 quarters. The position peaked at $21.3M in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • State of Alaska Department of Revenue reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • State of Alaska Department of Revenue sold 115,895 Alexion Pharmaceuticals shares in Q3 2021, an estimated $21.3M.
  • State of Alaska Department of Revenue first reported a position in Alexion Pharmaceuticals in Q3 2017 and held it in 16 quarters.
  • State of Alaska Department of Revenue's Alexion Pharmaceuticals position peaked at $21.3M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on State of Alaska Department of Revenue's 13F filing for Q3 2021, filed 7 Oct 2021.